Krystal Biotech, Inc.
KRYS
$183.92
$1.170.64%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | 8.70% | 19.29% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 8.70% | 19.29% | |||
Cost of Revenue | -25.96% | 11.23% | |||
Gross Profit | 11.71% | 20.04% | |||
SG&A Expenses | 8.97% | 3.93% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 1.74% | -0.63% | |||
Operating Income | 18.45% | 65.83% | |||
Income Before Tax | 63.29% | 85.53% | |||
Income Tax Expenses | 20.93% | 442.77% | |||
Earnings from Continuing Operations | 67.33% | 74.59% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 67.33% | 74.59% | |||
EBIT | 18.45% | 65.83% | |||
EBITDA | 18.06% | 57.70% | |||
EPS Basic | 67.10% | 73.86% | |||
Normalized Basic EPS | 14.85% | 47.48% | |||
EPS Diluted | 67.71% | 71.70% | |||
Normalized Diluted EPS | 15.08% | 46.76% | |||
Average Basic Shares Outstanding | 0.14% | 0.41% | |||
Average Diluted Shares Outstanding | -0.06% | 0.89% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |